Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mycosis fungoides (MF) and its variants represent the most common forms of cutaneous T-cell lymphomas. The term MF is restricted to the classical form characterized by the slow progression of patches, plaques and tumors, and to variants with a similar indolent course.
Biomarker and diagnostic research for mycosis fungoides and variants has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for mycosis fungoides and variants.
87 publications have been identified in PubMed for mycosis fungoides and variants. Research spans Case Report / Case Series (52%), Review / Meta-Analysis (24%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 45 | 52% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:49 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
21 |
24% |
Disease patterns and progression | 9 | 10% |
Laboratory research | 5 | 6% |
New treatment approaches | 4 | 5% |
Testing and diagnosis research | 2 | 2% |
Clinical study results | 1 | 1% |
Bai H (2026). [PMID: 41189357](https://pubmed.ncbi.nlm.nih.gov/41189357/). *Journal of cutaneous pathology*. [Case Report / Case Series]
Bowers JT (2026). [PMID: 42192920](https://pubmed.ncbi.nlm.nih.gov/42192920/). *Cancers (Basel)*. [Review / Meta-Analysis]
Singh AP (2026). [PMID: 41371249](https://pubmed.ncbi.nlm.nih.gov/41371249/). *Journal of cutaneous pathology*. [Case Report / Case Series]
Nishida M (2026). [PMID: 42007626](https://pubmed.ncbi.nlm.nih.gov/42007626/). *J Dermatol*. [Case Report / Case Series]
Longo M (2026). [PMID: 41716458](https://pubmed.ncbi.nlm.nih.gov/41716458/). *Frontiers in cellular and infection microbiology*. [Case Report / Case Series]
Filippatos C (2026). [PMID: 41988991](https://pubmed.ncbi.nlm.nih.gov/41988991/). *Am J Hematol*. [Epidemiology / Natural History]
Akkad N (2026). [PMID: 41988788](https://pubmed.ncbi.nlm.nih.gov/41988788/). *Expert Opin Investig Drugs*. [Review / Meta-Analysis]
Johnson NA (2026). [PMID: 41646541](https://pubmed.ncbi.nlm.nih.gov/41646541/). *Skin health and disease*. [Case Report / Case Series]
Souza BCE (2026). [PMID: 41414819](https://pubmed.ncbi.nlm.nih.gov/41414819/). *The Journal of dermatology*. [Case Report / Case Series]
Bhabha F (2026). [PMID: 41447501](https://pubmed.ncbi.nlm.nih.gov/41447501/). *Leukemia & lymphoma*. [Review / Meta-Analysis]
AI-curated news mentioning mycosis fungoides and variants
Updated Aug 26, 2026
Recent research highlights oral mycosis fungoides, a rare form of cutaneous T-cell lymphoma affecting the oral cavity. This study contributes to the understanding of its clinical presentation and management.
A recent study highlights the psychological distress and symptom burden faced by patients with mycosis fungoides and Sézary syndrome, impacting their overall quality of life. This research underscores the need for comprehensive care strategies addressing both physical and mental health in these patients.
A retrospective cohort study evaluates the prognostic value of skin lesion characteristics in subcutaneous panniculitis-like T-cell lymphoma. The research assesses the applicability of the T category of the TNM classification for primary cutaneous lymphomas, excluding mycosis fungoides and Sézary syndrome.